Cerus
CERS
#7698
Rank
โ‚ฌ0.30 B
Marketcap
1,61ย โ‚ฌ
Share price
-9.66%
Change (1 day)
-5.24%
Change (1 year)

Cerus (CERS) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ84.29 Million

According to Cerus's latest financial reports the company's total debt is โ‚ฌ84.29 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Cerus - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ94.26 M8.55%
2023-12-31โ‚ฌ86.84 M6.78%
2022-12-31โ‚ฌ81.32 M5.16%
2021-12-31โ‚ฌ77.33 M42.21%
2020-12-31โ‚ฌ54.38 M-5.47%
2019-12-31โ‚ฌ57.53 M120.35%
2018-12-31โ‚ฌ26.11 M5.14%
2017-12-31โ‚ฌ24.83 M34.83%
2016-12-31โ‚ฌ18.41 M1.7%
2015-12-31โ‚ฌ18.11 M123.14%
2014-12-31โ‚ฌ8.11 M233.03%
2013-12-31โ‚ฌ2.43 M-58.26%
2012-12-31โ‚ฌ5.83 M5.09%
2011-12-31โ‚ฌ5.55 M51.02%
2010-12-31โ‚ฌ3.67 M21864.32%
2009-12-31โ‚ฌ0.01 M
2008-12-31N/A-100%
2007-12-31โ‚ฌ0.02 M-75.07%
2006-12-31โ‚ฌ0.08 M-97.9%
2005-12-31โ‚ฌ4.18 M-85.43%
2004-12-31โ‚ฌ28.75 M-35.19%
2003-12-31โ‚ฌ44.36 M90830.98%
2002-12-31โ‚ฌ0.04 M-47.46%
2001-12-31โ‚ฌ0.09 M-24.6%
2000-12-31โ‚ฌ0.12 M-15.13%
1999-12-31โ‚ฌ0.14 M
1997-12-31โ‚ฌ0.08 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Haemonetics
HAE
โ‚ฌ1.05 B 1,147.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ0.47 M-99.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
โ‚ฌ10.34 B 12,168.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
โ‚ฌ0.21 M-99.74%๐Ÿ‡บ๐Ÿ‡ธ USA